Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

NCT01199640 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.